Kashiwagi, H., McDunn, J. E., Simon, P. O., Goedegebuure, P. S., Vangveravong, S., Chang, K., . . . Hawkins, W. G. (2009). Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma. BioMed Central.
Chicago Style citaatKashiwagi, Hiroyuki, Jonathan E. McDunn, Peter O. Simon, Peter S. Goedegebuure, Suwanna Vangveravong, Katherine Chang, Richard S. Hotchkiss, Robert H. Mach, en William G. Hawkins. Sigma-2 Receptor Ligands Potentiate Conventional Chemotherapies and Improve Survival in Models of Pancreatic Adenocarcinoma. BioMed Central, 2009.
MLA citatieKashiwagi, Hiroyuki, et al. Sigma-2 Receptor Ligands Potentiate Conventional Chemotherapies and Improve Survival in Models of Pancreatic Adenocarcinoma. BioMed Central, 2009.